HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin E Gleave Selected Research

LIT receptor

4/2011Human prostate cancer xenografts in lit/lit mice exhibit reduced growth and androgen-independent progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin E Gleave Research Topics

Disease

180Prostatic Neoplasms (Prostate Cancer)
01/2022 - 02/2002
145Neoplasms (Cancer)
11/2021 - 05/2002
19Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 06/2004
16Neoplasm Metastasis (Metastasis)
01/2022 - 05/2002
12Adenocarcinoma
01/2022 - 05/2012
6Reperfusion Injury
01/2022 - 03/2010
6Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 05/2002
6Disease Progression
01/2018 - 06/2009
5Carcinoma (Carcinomatosis)
01/2022 - 01/2016
4Inflammation (Inflammations)
01/2021 - 03/2012
4Non-Muscle Invasive Bladder Neoplasms
05/2011 - 06/2008
3Hypoxia (Hypoxemia)
01/2021 - 11/2015
3Margins of Excision
11/2016 - 09/2012
3Carcinogenesis
03/2014 - 09/2004
3Breast Neoplasms (Breast Cancer)
01/2010 - 08/2005
2Melanoma (Melanoma, Malignant)
12/2019 - 06/2005
2Residual Neoplasm
11/2017 - 05/2017
2Extranodal Extension
11/2016 - 06/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2015 - 03/2012

Drug/Important Bio-Agent (IBA)

72AndrogensIBA
01/2022 - 02/2002
56Androgen Receptors (Androgen Receptor)IBA
11/2021 - 06/2004
45Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2002
43ClusterinIBA
01/2022 - 02/2002
31Hormones (Hormone)IBA
01/2021 - 02/2002
25Antisense OligonucleotidesIBA
10/2020 - 05/2002
19Pharmaceutical PreparationsIBA
06/2021 - 09/2007
19Prostate-Specific Antigen (Semenogelase)IBA
01/2018 - 07/2003
16enzalutamideIBA
01/2021 - 01/2015
15Biomarkers (Surrogate Marker)IBA
10/2020 - 02/2010
14Docetaxel (Taxotere)FDA Link
11/2017 - 09/2005
11Messenger RNA (mRNA)IBA
10/2020 - 07/2003
10OGX-011IBA
03/2012 - 08/2005
10Paclitaxel (Taxol)FDA LinkGeneric
12/2011 - 03/2004
9Transcription Factors (Transcription Factor)IBA
01/2020 - 09/2008
8Phosphotransferases (Kinase)IBA
11/2021 - 06/2004
8DNA (Deoxyribonucleic Acid)IBA
12/2020 - 07/2012
8Small Interfering RNA (siRNA)IBA
10/2015 - 03/2004
8OligonucleotidesIBA
11/2011 - 02/2002
8OligodeoxyribonucleotidesIBA
01/2007 - 06/2004
7SteroidsIBA
01/2021 - 08/2008
7Testosterone (Sustanon)FDA Link
10/2019 - 05/2007
6EnzymesIBA
09/2018 - 03/2004
6apatorsenIBA
01/2018 - 08/2008
6Biological ProductsIBA
04/2017 - 08/2005
6RNA (Ribonucleic Acid)IBA
01/2017 - 11/2011
5LigandsIBA
03/2021 - 10/2013
5Cell-Free Nucleic AcidsIBA
12/2020 - 05/2015
5Circulating Tumor DNAIBA
01/2020 - 12/2017
5PlatinumIBA
11/2019 - 03/2012
5abirateroneIBA
01/2019 - 01/2015
5Androgen Antagonists (Antiandrogens)IBA
10/2017 - 08/2008
5Insulin-Like Growth Factor I (IGF-1)IBA
03/2014 - 07/2003
4Prednisone (Sone)FDA LinkGeneric
12/2019 - 09/2010
4Glucose (Dextrose)FDA LinkGeneric
07/2018 - 10/2015
4Cisplatin (Platino)FDA LinkGeneric
04/2018 - 02/2005
4Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2016 - 08/2008
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2015 - 07/2003
4Glycoproteins (Glycoprotein)IBA
06/2015 - 03/2004
4Insulin-Like PeptidesIBA
12/2014 - 06/2006
4IGF Type 1 Receptor (IGF 1 Receptor)IBA
11/2013 - 12/2004
4Insulin (Novolin)FDA Link
09/2011 - 01/2009
4AntibodiesIBA
01/2009 - 06/2004
3Ointments (Pastes)IBA
01/2021 - 09/2005
3Abiraterone AcetateIBA
12/2019 - 05/2015
3Semaphorins (Semaphorin)IBA
12/2018 - 01/2017
3Lactic Acid (Lactate)FDA LinkGeneric
07/2018 - 01/2016
3HSP27 Heat-Shock ProteinsIBA
01/2018 - 07/2014
3bicalutamide (Casodex)FDA LinkGeneric
01/2018 - 06/2012
3Complementary DNA (cDNA)IBA
12/2016 - 05/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2016 - 07/2010
3capivasertibIBA
06/2015 - 02/2013
3Levodopa (L Dopa)FDA LinkGeneric
06/2012 - 01/2007
3Carboxy-LyasesIBA
06/2012 - 01/2007
3GemcitabineFDA Link
03/2012 - 06/2004
3HTI-286IBA
08/2009 - 03/2008
3CholesterolIBA
07/2009 - 03/2004
2darolutamideIBA
06/2021 - 01/2018
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
12/2020 - 02/2013
2Protein Isoforms (Isoforms)IBA
10/2020 - 01/2007
2Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2020 - 08/2015
2Leuprolide (Lupron)FDA LinkGeneric
10/2019 - 05/2017
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2019 - 05/2017
2tyrosine receptor (receptor, tyrosine)IBA
12/2018 - 01/2018
2Vitamin DFDA LinkGeneric
04/2018 - 08/2005
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2017 - 02/2017
2Sunitinib (Sutent)FDA Link
11/2015 - 10/2015
2integrin-linked kinaseIBA
04/2015 - 02/2012
2Cadherins (E-Cadherin)IBA
04/2015 - 02/2012
2GlucocorticoidsIBA
02/2015 - 01/2007
2Insulin ReceptorIBA
12/2014 - 01/2009

Therapy/Procedure

90Therapeutics
01/2022 - 02/2002
78Castration
01/2022 - 07/2003
22Prostatectomy (Retropubic Prostatectomy)
01/2022 - 09/2002
17Drug Therapy (Chemotherapy)
10/2020 - 03/2003
8Intravesical Administration
01/2021 - 06/2004
8Radiotherapy
01/2019 - 10/2002
4Aftercare (After-Treatment)
01/2018 - 12/2003
3Precision Medicine
12/2015 - 08/2014
2Neoadjuvant Therapy
01/2021 - 05/2017
2Immunotherapy
01/2021 - 11/2019